BioSpace News Archive

Business

MedMira Announces the Hire of Vice President of Business Development

MedMira Inc. is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the position of Vice President of Business Development.

April 30, 2024
·
3 min read
Pharm Country

Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting

Integra LifeSciences Holdings Corporation is pleased to announce that following a successful Q1 2024 U.S. relaunch of its CereLink® ICP Monitoring System, the innovative product will be featured at the upcoming AANS Annual Scientific Meeting from May 3 through 6, 2024, in Chicago, Illinois.

April 30, 2024
·
4 min read
Business

TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update

TG Therapeutics, Inc., announced that a conference call will be held tomorrow, Wednesday, May 1, 2024, at 8:30 AM ET to discuss results for the first quarter of 2024 and provide a business outlook for 2024.

April 30, 2024
·
1 min read
Biotech Bay

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - April 30, 2024

Adicet Bio, Inc., a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, announced it granted an inducement award on April 30, 2024.

April 30, 2024
·
2 min read
BioCapital

Emergent BioSolutions Announces Amendment to its Existing Credit Facility

Emergent BioSolutions Inc. announced that it has entered into a “Consent, Waiver and Seventh Amendment” to its existing credit facility.

April 30, 2024
·
2 min read
Drug Development

Jacobio Pharma Announced its KRAS G12C inhibitor reached the primary endpoint

Jacobio Pharma announced that the data from the Phase II registrational study of the KRAS G12C inhibitor glecirasib were offically reported at the April ASCO Plenary Series, which was held online.

April 30, 2024
·
3 min read
Business

Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, will hold its first quarter earnings conference call on Tuesday, May 7, 2024 at 4:30pm ET.

April 30, 2024
·
2 min read
Business

CooperCompanies Announces Release Date for Second Quarter 2024

CooperCompanies announced it will report second quarter 2024 financial results on Thursday, May 30, 2024, at 4:15 PM ET.

April 30, 2024
·
1 min read
Business

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2024 ended March 31, 2024, after the market closes on Wednesday, May 8, 2024, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.

April 30, 2024
·
3 min read